Treatment:
CXCL12 S1824-p
dasatinib S749-p
EGF S1827-p
ephrin_B1 Y1725-p , Y1919-p
gefitinib Y1919-p
ischemia S1545-p , S1824-p , S1827-p
LRRK2-IN-1 S1442-p
metastatic potential S1458-p
nocodazole S400-p , S404-p , T1159-p
selumetinib S1442-p , S1530-p , S1534-p
vemurafenib S1442-p , S1530-p , S1534-p
Y27632 S169-p , S428-p , T434-p , S1458-p , T1829-p